News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

Gareth Morgan, MS, MBA

Advertisement

Morgan, MS, MBA, president, Qpex Biopharma.

Articles by Gareth Morgan, MS, MBA

Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists

ByGareth Morgan, MS, MBA,John Parkinson
October 30th 2025

In his new position, Gareth Morgan, MS, MBA, provides insights on antibiotic development strategies he would like to see during his tenure.

Advertisement

Latest Updated Articles

  • Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists
    Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists

    Published: October 30th 2025 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Meets Primary Endpoint in Phase 3 Study

2

Zoliflodacin Emerges as a First-in-Class Oral Option Against Drug-Resistant Gonorrhea

3

FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea

4

A Pediatrician’s Perspective on the Latest ACIP Hepatitis B Vaccine Recommendations

5

Top Infectious Disease News Stories Week of December 6 - December 12

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us